Merck’s pneumococcal disease vaccine for adults granted FDA approval
Introducing Merck’s New Pneumococcal Vaccine: Capvaxive The Food and Drug Administration recently approved Merck’s new pneumococcal vaccine, Capvaxive, designed to protect adults from a bacteria known as pneumococcus. This bacterium can cause serious illnesses and … Read more